CASTELLUM INC (CTM) Fundamental Analysis & Valuation
NYSEARCA:CTM • US14838T2042
Current stock price
0.7191 USD
+0.04 (+5.44%)
At close:
0.7274 USD
+0.01 (+1.15%)
After Hours:
This CTM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. CTM Profitability Analysis
1.1 Basic Checks
- CTM had negative earnings in the past year.
- In the past year CTM has reported a negative cash flow from operations.
- In the past 5 years CTM always reported negative net income.
- In multiple years CTM reported negative operating cash flow during the last 5 years.
1.2 Ratios
- CTM's Return On Assets of -5.98% is on the low side compared to the rest of the industry. CTM is outperformed by 64.77% of its industry peers.
- Looking at the Return On Equity, with a value of -7.01%, CTM is in line with its industry, outperforming 46.59% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.98% | ||
| ROE | -7.01% | ||
| ROIC | N/A |
ROA(3y)-30.73%
ROA(5y)-32.44%
ROE(3y)-65.14%
ROE(5y)-66.07%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- CTM has a Gross Margin (36.64%) which is in line with its industry peers.
- CTM's Gross Margin has declined in the last couple of years.
- The Profit Margin and Operating Margin are not available for CTM so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 36.64% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.23%
GM growth 5Y-4.58%
2. CTM Health Analysis
2.1 Basic Checks
- CTM does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for CTM has been increased compared to 1 year ago.
- The number of shares outstanding for CTM has been increased compared to 5 years ago.
- Compared to 1 year ago, CTM has an improved debt to assets ratio.
2.2 Solvency
- CTM has an Altman-Z score of 5.99. This indicates that CTM is financially healthy and has little risk of bankruptcy at the moment.
- With an excellent Altman-Z score value of 5.99, CTM belongs to the best of the industry, outperforming 88.64% of the companies in the same industry.
- CTM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 5.99 |
ROIC/WACCN/A
WACC10.1%
2.3 Liquidity
- A Current Ratio of 4.40 indicates that CTM has no problem at all paying its short term obligations.
- CTM's Current ratio of 4.40 is amongst the best of the industry. CTM outperforms 86.36% of its industry peers.
- CTM has a Quick Ratio of 4.40. This indicates that CTM is financially healthy and has no problem in meeting its short term obligations.
- CTM's Quick ratio of 4.40 is amongst the best of the industry. CTM outperforms 86.36% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.4 | ||
| Quick Ratio | 4.4 |
3. CTM Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 85.19% over the past year.
- Looking at the last year, CTM shows a quite strong growth in Revenue. The Revenue has grown by 18.10% in the last year.
- Measured over the past years, CTM shows a very strong growth in Revenue. The Revenue has been growing by 31.71% on average per year.
EPS 1Y (TTM)85.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.1%
Revenue 1Y (TTM)18.1%
Revenue growth 3Y7.81%
Revenue growth 5Y31.71%
Sales Q2Q%21.94%
3.2 Future
- Based on estimates for the next years, CTM will show a decrease in Earnings Per Share. The EPS will decrease by 0.00% on average per year.
- Based on estimates for the next years, CTM will show a quite strong growth in Revenue. The Revenue will grow by 10.87% on average per year.
EPS Next Y0%
EPS Next 2Y0%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year15.57%
Revenue Next 2Y10.87%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. CTM Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for CTM. In the last year negative earnings were reported.
- The Price/Forward Earnings ratio is 35.60, which means the current valuation is very expensive for CTM.
- The rest of the industry has a similar Price/Forward Earnings ratio as CTM.
- CTM's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 38.20.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 35.6 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0%
EPS Next 3YN/A
5. CTM Dividend Analysis
5.1 Amount
- No dividends for CTM!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
CTM Fundamentals: All Metrics, Ratios and Statistics
0.7191
+0.04 (+5.44%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)03-09 2026-03-09/amc
Earnings (Next)05-07 2026-05-07
Inst Owners13.73%
Inst Owner Change0%
Ins Owners8.72%
Ins Owner Change-2.72%
Market Cap68.03M
Revenue(TTM)52.87M
Net Income(TTM)-2.51M
Analysts80
Price Target3.57 (396.45%)
Short Float %6.41%
Short Ratio4.3
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-5.03%
Min Revenue beat(2)-12.48%
Max Revenue beat(2)2.43%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-100%
EPS NQ rev (3m)-100%
EPS NY rev (1m)-33.33%
EPS NY rev (3m)-33.33%
Revenue NQ rev (1m)-6.73%
Revenue NQ rev (3m)-6.73%
Revenue NY rev (1m)3.27%
Revenue NY rev (3m)3.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 35.6 | ||
| P/S | 1.29 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.9 | ||
| P/tB | 3.45 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.03
EYN/A
EPS(NY)0.02
Fwd EY2.81%
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.56
BVpS0.38
TBVpS0.21
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.98% | ||
| ROE | -7.01% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 36.64% | ||
| FCFM | N/A |
ROA(3y)-30.73%
ROA(5y)-32.44%
ROE(3y)-65.14%
ROE(5y)-66.07%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.23%
GM growth 5Y-4.58%
F-Score5
Asset Turnover1.26
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 10.12% | ||
| Cap/Sales | 0.29% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 4.4 | ||
| Quick Ratio | 4.4 | ||
| Altman-Z | 5.99 |
F-Score5
WACC10.1%
ROIC/WACCN/A
Cap/Depr(3y)3.66%
Cap/Depr(5y)3.19%
Cap/Sales(3y)0.11%
Cap/Sales(5y)0.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)85.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.1%
EPS Next Y0%
EPS Next 2Y0%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)18.1%
Revenue growth 3Y7.81%
Revenue growth 5Y31.71%
Sales Q2Q%21.94%
Revenue Next Year15.57%
Revenue Next 2Y10.87%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y61.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year168.73%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-288.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-273.95%
OCF growth 3YN/A
OCF growth 5YN/A
CASTELLUM INC / CTM Fundamental Analysis FAQ
What is the fundamental rating for CTM stock?
ChartMill assigns a fundamental rating of 4 / 10 to CTM.
What is the valuation status of CASTELLUM INC (CTM) stock?
ChartMill assigns a valuation rating of 1 / 10 to CASTELLUM INC (CTM). This can be considered as Overvalued.
Can you provide the profitability details for CASTELLUM INC?
CASTELLUM INC (CTM) has a profitability rating of 1 / 10.
Can you provide the financial health for CTM stock?
The financial health rating of CASTELLUM INC (CTM) is 8 / 10.